| scholarly article | Q13442814 |
| P50 | author | David W Sandall | Q59554736 |
| P2093 | author name string | Z Khalil | |
| K R Gayler | |||
| B G Livett | |||
| V Pham | |||
| D A Keays | |||
| J G Down | |||
| M A Polidano | |||
| N Satkunanathan | |||
| X Liping | |||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6904-6911 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | Biochemistry | Q764876 |
| P1476 | title | A novel alpha-conotoxin identified by gene sequencing is active in suppressing the vascular response to selective stimulation of sensory nerves in vivo | |
| P478 | volume | 42 |
| Q33459289 | A 'conovenomic' analysis of the milked venom from the mollusk-hunting cone snail Conus textile--the pharmacological importance of post-translational modifications |
| Q27676650 | A novel µ-conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors |
| Q33621205 | Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors |
| Q37336577 | Alpha9 nicotinic acetylcholine receptors and the treatment of pain |
| Q44676738 | Analgesic alpha-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation. |
| Q36159142 | Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type (Ca(V) 2.2) calcium channels |
| Q90601800 | Antiinflammatory peptides: current knowledge and promising prospects |
| Q33782635 | Atypical alpha-conotoxin LtIA from Conus litteratus targets a novel microsite of the alpha3beta2 nicotinic receptor |
| Q27675258 | Characterization of a Novel -Conotoxin from Conus textile That Selectively Targets 6/ 3 2 3 Nicotinic Acetylcholine Receptors |
| Q34156116 | Chemical synthesis and characterization of two α4/7-conotoxins |
| Q35432836 | Cone snail venomics: from novel biology to novel therapeutics |
| Q26783037 | Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management? |
| Q38088765 | Conotoxin therapeutics: a pipeline for success? |
| Q33736765 | Conotoxins targeting nicotinic acetylcholine receptors: an overview |
| Q46364124 | Conotoxins: Therapeutic Potential and Application |
| Q33668630 | Determinants of alpha-conotoxin BuIA selectivity on the nicotinic acetylcholine receptor beta subunit |
| Q35195853 | Discovery by proteogenomics and characterization of an RF-amide neuropeptide from cone snail venom |
| Q28481593 | Discovery of defense- and neuropeptides in social ants by genome-mining |
| Q28539516 | Diversity of conotoxin gene superfamilies in the venomous snail, Conus victoriae |
| Q35063148 | Embryonic toxin expression in the cone snail Conus victoriae: primed to kill or divergent function? |
| Q35104827 | From smoking to cancers: novel targets to neuronal nicotinic acetylcholine receptors |
| Q37348886 | Identifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors. |
| Q37695948 | Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain |
| Q35974234 | Less is More: Design of a Highly Stable Disulfide-Deleted Mutant of Analgesic Cyclic α-Conotoxin Vc1.1. |
| Q92343691 | Marine Toxins and Nociception: Potential Therapeutic Use in the Treatment of Visceral Pain Associated with Gastrointestinal Disorders |
| Q46272595 | Molecular Engineering of Conus Peptides as Therapeutic Leads |
| Q91699841 | Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors |
| Q24673308 | Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors |
| Q36890894 | Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity. |
| Q64250595 | Mutagenesis of α-Conotoxins for Enhancing Activity and Selectivity for Nicotinic Acetylcholine Receptors |
| Q30399297 | NMR and protein structure in drug design: application to cyclotides and conotoxins |
| Q47739924 | Nicotinic acetylcholine receptors in neuropathic and inflammatory pain. |
| Q38579158 | Novel coupling is painless |
| Q88735145 | Pain therapeutics from cone snail venoms: From Ziconotide to novel non-opioid pathways |
| Q35795241 | Physico-chemical characterization and synthesis of neuronally active alpha-conotoxins |
| Q50111328 | Potential Uses of Isolated Toxin Peptides in Neuropathic Pain Relief: A Literature Review |
| Q37385244 | Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1. |
| Q27643878 | Protein Folding Determinants: Structural Features Determining Alternative Disulfide Pairing in α- and χ/λ-Conotoxins † , ‡ |
| Q39897555 | Rational design of alpha-conotoxin analogues targeting alpha7 nicotinic acetylcholine receptors: improved antagonistic activity by incorporation of proline derivatives |
| Q61813624 | Rationally Designed α-Conotoxin Analogues Maintained Analgesia Activity and Weakened Side Effects |
| Q37148710 | Receptor and channel heteromers as pain targets |
| Q37339057 | Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor |
| Q35637410 | Snake and snail toxins acting on nicotinic acetylcholine receptors: fundamental aspects and medical applications |
| Q35947186 | Structure-Activity Studies of Cysteine-Rich α-Conotoxins that Inhibit High-Voltage-Activated Calcium Channels via GABA(B) Receptor Activation Reveal a Minimal Functional Motif. |
| Q27681882 | Structure-Function Elucidation of a New -Conotoxin, Lo1a, from Conus longurionis |
| Q35795248 | Structure-activity relationships of alpha-conotoxins targeting neuronal nicotinic acetylcholine receptors |
| Q37954299 | Synthetic α-conotoxin mutants as probes for studying nicotinic acetylcholine receptors and in the development of novel drug leads |
| Q37882724 | Targeted biological therapies for pain. |
| Q36871977 | Targeting the alpha9alpha10 nicotinic acetylcholine receptor to treat severe pain |
| Q33744170 | The Venom Repertoire of Conus gloriamaris (Chemnitz, 1777), the Glory of the Sea. |
| Q35547518 | The novel small molecule α9α10 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesic |
| Q46777407 | The three-dimensional structure of the analgesic alpha-conotoxin, RgIA. |
| Q38026605 | Therapeutic potential of conopeptides |
| Q28207222 | Therapeutic potential of venom peptides |
| Q52361555 | Venomics-Accelerated Cone Snail Venom Peptide Discovery. |
| Q36784217 | alpha4/7-conotoxin Lp1.1 is a novel antagonist of neuronal nicotinic acetylcholine receptors |
| Q39405111 | α9-containing nicotinic acetylcholine receptors and the modulation of pain. |
| Q34333395 | α9-nicotinic acetylcholine receptors contribute to the maintenance of chronic mechanical hyperalgesia, but not thermal or mechanical allodynia |
| Q36078883 | γ-Aminobutyric acid type B (GABAB) receptor expression is needed for inhibition of N-type (Cav2.2) calcium channels by analgesic α-conotoxins |
Search more.